CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist
  • 28.83
  • +0.12+0.42%
Market Closed Mar 18 15:00 CST
14.54BMarket Cap36.63P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China Resources Boya Bio-pharmaceutical Group Q4 2024 Earnings Date

Currency：CNYMar 19, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
399.00M
489.80M
+90.80M
Beat Est.
-13.56%
+6.11%
+22.76%
Net Income
--
-15.90M
--
+92.96%
Analyst Rating
Strong Buy

Mar 18, 2025

China Resources Boya Bio-pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 501.000M--
--2025/Q1-- / 550.000M--
Mar 19, 20252024/Q4489.797M / 399.000M--
Oct 25, 20242024/Q3349.372M / 512.000M--
Aug 24, 20242024/Q2447.283M / 417.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 501.000M--
--2025/Q1-- / 550.000M--
Mar 19, 20252024/Q4489.797M / 399.000M--
Oct 25, 20242024/Q3349.372M / 512.000M--
Aug 24, 20242024/Q2447.283M / 417.000M--

Unlock Free Earnings Estimates

China Resources Boya Bio-pharmaceutical Group Earnings Reports

  • Liberal Arts Biotech: 2024 Annual Report Summary

    12:00 ET

  • Liberal Arts Biotech: 2024 Annual Report

    12:00 ET

  • Liberal Arts Biotech: 2024 Annual Results Forecast

    Jan 22 03:22 ET

  • Liberal Arts Biotech: Report for the third quarter of 2024

    Oct 24, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Guangdong Hongjing Optoelectronic Technology Inc.
    301479
    160.07 +282.03%
    LTECH
    832110
    51.58 +29.99%
    FZFM
    920082
    27.94 +24.29%
    JiangSu Jinji Industrial
    300798
    9.58 +20.05%
    Shandong Nanshan Fashion Sci-Tech
    300918
    21.34 +20.02%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 18, 2025

    Strong Buy

    • Strong Buy

      91.67%

    • Buy

      4.17%

    • Hold

      4.17%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Biomedical
    Biomedical
    Intraday+0.73%
    Blood Products Concept
    Blood Products Concept
    Intraday+0.71%
    Biological Vaccine
    Biological Vaccine
    Intraday+0.49%